Ccr.cancer.gov

In an ongoing NCI-led clinical trial at the NIH Clinical Center, a patient with metastatic breast cancer has experienced complete regression of her disease after treatment with an experimental immunotherapy developed in CCR. Despite multiple prior...

People with prostate or kidney cancer that has not responded to standard treatments may be eligible to participate in a clinical trial at the NIH Clinical Center.

People with metastatic, non-prostate genitourinary cancers may be eligible to participate in a clinical trial at the NIH Clinical Center.

The Lipkowitz laboratory of the Women's Malignancies Branch is looking for a Postdoctoral Fellow. The laboratory investigates signal transduction pathways that regulate growth and programmed cell death in epithelial cancer cells. The ongoing...

A phase I/II clinical trial at the NIH Clinical Center will test the effectiveness of a vaccine against cancers linked to the human papillomavirus (HPV). The vaccine will be tested alone and in combination with a checkpoint inhibitor called M7824....

A phase 1 clinical trial of chimeric antigen receptor (CAR) T-cell therapy, which involves re-engineering patients’ own immune cells to attack cancer cells, has demonstrated previously unheard of remissions of up to five years in relapsed B-cell...

Patients with solid tumors or small-cell cancer in or outside the lungs may be eligible to participate in a clinical trial at the NIH Clinical Center.

People 18 years and older with confirmed HPV+ cancers may be eligible to participate in a new clinical trial at the NIH Clinical Center.

Key roles/responsibilities: The Laboratory of Pathology (LP) is seeking a post-doctoral fellow to conduct research in cancer genomics.  As part of the NCI-COMPASS program the LP is developing a robust multiomics program which includes clinical-grade...

Patients with colon cancer that has metastasized to the liver may be eligible to participate in a clinical trial at the NIH Clinical Center.

Women's Malignancies Branch: Our Teams Our Branch is involved in both clinical trials and laboratory research, allowing us to translate new discoveries found in the lab into new treatment options for our patients.  Visit each team leader's web...

CCR researchers used a state-of-the-art imaging technique to observe the journey neutrophils take when they leave the blood vessels and travel to an area of inflammation, in this case, bacteria introduced into a mouse’s hind footpad. The images...

CCR physician-scientists have launched a clinical trial to evaluate whether the immune-stimulating molecule NHS-IL12, alone or in combination with an experimental immunotherapy called M7824, reduces tumors in patients with Kaposi sarcoma.

Physician-Scientist Early Investigator Program CCR’s Physician-Scientist Early Investigator Program (PEIP) is a highly competitive opportunity intended for physicians dedicated to laboratory bench-to-bedside or clinic-based research. This position...

Adam Sowalsky, Ph.D., is an Investigator in the Laboratory of Genitourinary Cancer Pathogenesis. He is seeking to tease apart the molecular mechanisms underlying prostate cancers that have a high likelihood of progressing and then identifying...